Parents take an important role in follow-up of young cancer survivors. We aimed to investigate (1) parents' preferences for organisation of follow-up (including content, specialists involved and models of care), and (2) parents' and children's characteristics predicting preference for generalist vs. specialist-led follow-up. We sent a questionnaire to parents of childhood cancer survivors aged 11-17 years. We assessed on a 4-point Likert scale (1-4), parents' preferences for organisation of long-term follow-up.
| INTRODUCTION
Lifelong follow-up care is recommended for most childhood cancer survivors. The goal of follow-up is to identify and treat relapse and late effects early, and provide age-adapted information about cancer, treatment, potential late effects and health behaviour (Bhatia & Meadows, 2006; Hudson et al., 2013; Oeffinger et al., 2006; Taylor, Absolom, Snowden, & Eiser, 2012) . Guidelines have been developed to provide recommendations for risk-stratified long-term follow-up care (Children's Oncology Group, 2008; Scottish Intercollegiate Guidelines Network (SIGN), 2004; Wallace, Thompson, Anderson, & Guideline Development, 2013) . Various models of care have been described and compared (Heirs et al., 2013) such as follow-up by telephone (James, Guerrero, & Brada, 1994) , multidisciplinary team (MDT) (Carlson, Hobbie, Brogna, & Ginsberg, 2008; Edgar & Wallace, 2008) , paediatric oncologist (Haddy & Haddy, 2010) , general practitioners (GP) (Schmidt et al., 2010) or shared-care models (Blaauwbroek, Tuinier, Meyboom-de Jong, Kamps, & Postma, 2008) . In many countries, none of the models have been implemented and long-term follow-up is not standardised.
In Switzerland, childhood cancers survivors are regularly followed-up by their paediatric oncologist into their early 20s, and are then usually discharged to a GP or medical oncologist. Others may continue follow-up with their paediatric oncologist longer into adulthood.
Prior to setting up a specific model of follow-up care survivors' and their parents' opinions and preferences for the organisation of care should be assessed (Aslett, Levitt, Richardson, & Gibson, 2007; Earle, Davies, Greenfield, Ross, & Eiser, 2005) . Survivors' opinions and preferences have previously been studied (Michel et al., 2009 .
Parents' expectations of follow-up care have only been addressed in a small focus group study in the UK (Earle et al., 2005) : parents desired medical facts and written test results for reassurance, information on psychosocial consequences, and wanted to have the possibility to meet other families with a child survivor. Parents did not value the GP model since they perceived that specialist knowledge was not available.
Parents take an important role in follow-up care for many reasons: they are most aware about the child's medical history but also provide things such as transportation or reminding about doctor's appointment. We thus aimed to investigate (1) parents' preferences for the organisation of follow-up care (including content, specialists involved and different models of care). These outcomes were assessed for both children attending and not attending clinic-based follow-up. (2) We investigated associations of socio-demographic characteristics of parents and children's clinical factors with preferences for generalist vs.
specialist-led follow-up.
| METHODS

| Sample and procedure
The Swiss Childhood Cancer Registry (SCCR) is a national populationbased cancer registry including all cancer patients, diagnosed with leukaemia, lymphoma, central nervous system (CNS) tumour, malignant solid tumour or Langerhans cell histiocytosis at age <21 years in Switzerland since 1976 (Michel et al., 2007 (Michel et al., , 2008 . Parents of survivors aged ≤15 years completed the questionnaire for their children, whereas survivors 16+ years completed their own questionnaire.
The follow-up questionnaire was sent approximately 2 years later. Parents who filled in the baseline questionnaire were contacted again if their child who had cancer was aged 11-17 years at time of follow-up study (eligible N = 306; Figure S1 ). They received the questionnaire with a prepaid return envelope, and if they did not reply within 2 months, a reminder letter with another questionnaire.
Questionnaires were available in German and French and focused on topics related to follow-up care.
Ethics approval was provided through the general cancer registry permission of the SCCR (The Swiss Federal Commission of Experts for Professional Secrecy in Medical Research) and a non-obstat statement from the ethics committee of the canton of Bern declaring that the ethics committee did not object the conduct of the study.
| Measurements
The follow-up survey of the SCCSS focused on follow-up care and psychological outcomes. Follow-up care after childhood cancer was introduced on the front page of the questionnaire as follow-up appointments of their child due to the previous severe disease.
| Outcome
Items were purpose designed and based on a previous study in the UK (Michel et al., 2009) .
What are the reasons for follow-up: Parents rated the importance (1 = "not at all important" to 4 = "very important"; this scale was used in all questions where parents had to rate importance) of different reasons for attending follow-up (nine items).
What should be included in follow-up:
We asked parents about the perceived importance of four medical aspects and eight general aspects of follow-up ( Figure 1a) .
What is important during appointments:
Parents rated the importance of 10 organisational aspects (Figure 1a) . endocrinologists, psychologists, social workers and nurses, all of whom are accessible during one appointment). For each model, we asked parents' agreement to four items (1 = "don't agree at all" to 4 = "completely agree"): "it would suit my child", "I am afraid that health problems are not detected", "I am not satisfied with this kind of follow-up", this model of follow-up is appropriate for the needs of their child.
| Explanatory variables assessed by questionnaire
We assessed parents' sex, age at study, migration background (migration if they were not Swiss citizens since birth or not born in Switzerland), language region (German vs. French), parents' employment status (employed vs. not employed) and education (three categories: primary (compulsory schooling including vocational training/apprenticeship); secondary (teachers/technical and commercial schools, etc.); and tertiary (university and university of applied sciences; Table 1 ) .
Additionally, we asked parents if their child still attended follow-up:
(1) "yes, my child still attends regular follow-up appointments"; (2) "yes, my child still has irregular follow-up appointments"; (3) "no, regular follow-up is completed, but my child goes to the doctor for any cancerassociated complications"; (4) "no, regular follow-up is completed and my child has not seen the doctor for a while". A binary variable was created: attenders (responses 1 or 2) and non-attenders (responses 3 or 4).
Parents indicated on a list which doctors were involved in current care.
This was coded as "specialist care" if parents listed at least one specialist and "generalist" if only a GP was indicated. Parents were asked whether they are currently involved in follow-up care (parental involvement = yes/ no) . Concerns of parents about consequences of their child's illness were assessed by the question "How concerned are you about consequences of your child's illness?" (adapted from the Brief Illness Perception Questionnaire (IPQ) using a 0-to-10 response scale) (Broadbent, Petrie, Main, & Weinman, 2006) . The response was divided in three categories (no: 0-2, medium: 3-6 and high concerns: 7-10).
From the baseline questionnaire of the SCCSS, we extracted information about parent-reported late effects of the survivor (yes/no) .
| Clinical variables of the child extracted from the SCCR
We extracted medical information on cancer diagnosis and treatment of the child from the SCCR. Cancer diagnosis was classified according to the International Classification of Childhood Cancer (third edition) (Steliarova-Foucher, Stiller, Lacour, & Kaatsch, 2005) . For the analyses, we recoded diagnosis into six major groups: leukaemia, lymphoma, CNS tumours, neuroblastoma, bone tumour/soft tissue sarcoma and other tumours. Treatment was coded as: surgery only, chemotherapy (without radiotherapy ± surgery), radiotherapy (±sur-gery and/or chemotherapy) and stem cell transplantation (SCT; may have had surgery and/or chemotherapy and/or radiotherapy). The type of treating hospital was divided into university and regional hospital. Age at diagnosis was divided into three categories: 0-1, 2-4 and ≥5 years. We have chosen these categories because they might influence risk for late effects and preferences for follow-up care. Age at study was divided into three categories: <14, 14-15 and >15 years.
Time since diagnosis was divided into three categories 5-9, 10-14 and 15-17 years. Relapse was coded yes/no.
| Analyses
Analyses were performed using STaTa 13.1 (StataCorp, College Station, TX).
We used descriptive statistics to compare participants and nonparticipants of the study. To analyse difference in preferences between attenders and nonattenders, we used t-test and chi-squared test. Bonferroni correction was used to correct for multiple testing.
For aim 2, we determined the model with the highest mean for each parent and created a binary variable indicating if GP or telephone/questionnaire follow-up (generalist follow-up = 1) or any other follow-up model was rated highest (paediatric, medical oncologist, MDT: specialist follow-up = 0, Table 2 ). Telephone/questionnaire and GP led model were grouped into generalist model because survivors would first contact a health care provider not necessarily specialised in paediatric oncology and only be referred to a specialist if needed.
We used univariable logistic regression to investigate associations of parents' and their child's characteristics with the preferences for generalist vs. specialist follow-up.
| RESULTS
Of 306 eligible parents, we traced and contacted 284 ( Figure S2 ). Of those contacted, 189 (67%) responded. The mean age of parents was 46.1 years (SD = 4.8, range 33.5-59.5 years), mean age of the child at study was 14.8 years (SD = 1.8, range 10.7-18.0 years), mean age at diagnosis was 3.4 years (SD = 2.5 range 0-9.2 years) and the mean time since diagnosis 11.3 years (SD = 2.5, range 6.8-17.2 years; Table 1 ). Most children were diagnosed with leukaemia (39.2%) followed by CNS tumours (18.0%). Participating and non-participating parents were similar in socio-demographic and clinical characteristics (Table 1) .
| Parents' preferences for organisation of follow-up care
What are the reasons for follow-up: Factor analysis revealed two scales: supportive care (get reassurance about health, talk to staff who understand my child has been through, get advice about how to stay healthy, receive psychological support, get advice about everyday T A B L E 1 Characteristics of the study population, comparing parents participating and not participating in the questionnaire survey T There was no difference in preferences for follow-up between parents of attenders and non-attenders after Bonferroni correction (Table   S1 ).
| Associations with parents' preferences for generalist vs. specialist-led follow-up
We used logistic regression analyses to determine characteristics of parents and clinical characteristics of the child associated with preferences for generalists follow-up (GP and telephone/questionnaire) vs. specialist follow-up (paediatric or medical oncologist, MDT; A trend could be seen for lower preferences for generalist followup care for parents of children who had had a relapse (OR = 0.23, CI 0.03-1.78, p = .083) and who had been treated in a regional hospital (OR = 0.31, CI 0.07-1.39, p = .080).
| DISCUSSION
We found that clinical reasons to attend follow-up were more important than supportive reasons to parents of childhood cancer survivors aged 11-17 years. Medical aspects such as checking for cancer recurrence or screening for late effects were rated as most important. Parents wanted that their child is taken seriously and competent staff is available. Paediatric oncologists and GPs were rated as the preferred doctors. Parents' preferred model of care was paediatric oncologist-led follow-up or follow-up by a MDT.
The generalist model was only favoured by parents of children not attending follow-up care at a treating clinic or who already see a generalist.
The importance of medical aspects during follow-up was already reported in previous studies (Christen et al., 2016; Earle et al., 2005; Eiser, Levitt, Leiper, Havermans, & Donovan, 1996; Michel et al., 2009 Michel et al., , 2016 . We reported that screening for late effects and check for cancer recurrence was rated most important for parents which are
in line with what survivors reported. Parents want to be reassured about the cancer and know that their child is in best current health.
A focus group analysis of parents of survivors aged 13-25 years showed that it is important to learn about risks for future health but also about how to stay healthy (Earle et al., 2005) . This is in contrast to our results where the general aspects such as risk for offspring were rated less important. The survivors in our samples are young and future health might not be of biggest concern, however parents and survivors should be informed that many years after diagnosis the risk for cancer recurrence diminishes and follow-up care is of higher importance to screen for late effects and learn about healthy lifestyle (Reulen et al., 2010 ).
When we asked for the specialist whom should be involved, parents preferred the paediatric oncologist followed by the GP. This preference for the paediatric oncologist was in line with another Swiss study on childhood cancer survivors . In contrast to our findings, a previous focus group reported that follow-up at a GP was evaluated as not appropriate since the specialist knowledge was lacking, whereas clinics led by specialist nurses were perceived as more acceptable, in offering both specialist expertise and opportunities for appropriate feedback (Earle et al., 2005) . However, these survivors were still in clinic-based follow-up most likely by a paediatric oncologist and therefore possibly favouring this specialist. Even though second highest in our study, another study in the US on survivors showed that follow-up by primary care physicians was rated highest and the late effects specialist second highest only . Concerning might be that other studies reported that generalists lack knowledge and information on potential late effects or comfort of care for childhood cancer survivors (Lawrence, McLoone, Wakefield, & Cohn, 2016; Mertens et al., 2004) . Therefore, a close collaboration with specialist should be guaranteed and educational interventions for GPs if required organised. A Dutch study
showed that GP are willing to follow-up childhood cancer survivors in a shared-care model, however they saw lack of information and communication as a barrier (Blaauwbroek et al., 2007) . Therefore, written treatment summaries or a passport for care should be provided and help the GP guide through recommended screening and follow-up care processes (Horowitz, Fordis, Krause, McKellar, & Poplack, 2009 ).
Such a passport will be implemented across Switzerland within the next years.
We additionally showed that most parents preferred follow-up care by a paediatric oncologist or a MDT led model. The telephone/ questionnaire led model was least preferred. This is in line with two other studies among survivors who reported the paediatric oncologistled follow-up as most important and the telephone/questionnaire follow-up least important (Michel et al., 2009 . However, in the UK they only included survivors who attended clinic-based follow-up which was most likely led by a paediatric oncologist. Also, expert committees have often favoured long-term follow-up care clinics led by a MDT because late effects might be diverse and complex (Wallace et al., 2001) . With the ever growing population of survivors, follow-up care by paediatric oncologists, however, will not be feasible and manageable in Switzerland and MDT models might be too cost intensive.
Therefore, in Switzerland many survivors are transitioned to a GP.
Our results also indicated that parents of Swiss survivors still seeing a paediatric oncologist favour the paediatric oncologist-led follow-up, and parents whose children see a GP favour the generalist model.
These parents also know specialist care from the first 5-10 years follow-up by the paediatric oncologist. Our results thus suggest that a risk-stratified approach where low-risk survivors are transferred to GP-led follow-up could meet parents' preferences. These findings are supported by another Swiss study where we showed that adolescent and young adult survivors preferred follow-up by medical oncologists, most of whom were treated by medical oncologists (Christen et al., 2016) . As shown in another study on adult survivors, satisfaction with care did not depend on the clinic type but rather on shorter waiting time and possibilities to discuss health concerns . Parents and survivors preferences and satisfaction of care should be taken into account as it might ensure future attendance in follow-up.
We found no other clinical or socio-demographic associations for preferences for generalist-led follow-up care. Neither diagnosis nor late effects were associated with different preferences for follow-up care. However, there was some indication for a generalist preference in parents of survivors who did not have a relapse and those treated at a university hospital. This might suggest that preferences do not reflect the risk for late effects.
Our results and previous findings suggest that survivors and parents might be happy and feel comfortable with the model of care their children are currently receiving. Preference of care might be related to the satisfaction of care even though not measured in our study.
Parents' preferences of care should therefore be considered early on and, if possible, follow-up care should be framed taking their preferences into account. Being the primary caregiver of young survivors, their preference and satisfaction of care might ensure later attendance at follow-up care. However, parents should also be given adequate assurance and support in taking the decision on the future health care
provider. Alternative models and individual preferences of long-term follow-up should be discussed. Additionally, both health care providers and primary caregivers might profit from written treatment summaries and survivorship care plans and guarantee adequate follow-up. A riskstratified approach, where survivors receive follow-up care depending on diagnosis, and treatment (indicating their risk for late effects) might be the most adequate approach . However, for Switzerland such an approach has so far not been implemented (Rebholz, von der Weid, Michel, Niggli, & Kuehni, 2011) .
A limitation of this study is self-selection: parents of specific groups such as parents with greater interest in follow-up care or with higher needs may have been more willing to complete the questionnaire, others have been excluded because they did not complete the baseline questionnaire. Additionally, we only contacted one parent, mostly mothers, and thus information on preferences of the other parent is lacking. Also, we did not contact the survivors themselves in these families, and thus the preference of care of survivors is lacking.
Another limitation is that we cannot tell if this is what parents really prefer or what they have been told to do by the treating physician.
Further, we were not able to stratify survivors according to their risk because detailed information on exact treatment was lacking. The small sample size resulted in reduced precision and large confidence intervals. Therefore, only limited stratification of results was possible.
Other limitations are the low reliability of the scale "clinical reasons"
and the self-reported late effects.
Despite the relatively small sample size, this is a study with a rather large sample of parents of childhood cancer survivors compared to previous research. We were able to include parents of survivors attending and not attending clinic-based follow-up, and included prospectively collected data from the SCCR and from two questionnaires from the SCCSS. The response rate was good (67%).
Follow-up is an important aspect of quality of survivorship. In the transitioning phase from child to adult care, it is important to not only meet survivors' or providers' preferences, but also parents' preferences for the organisation of follow-up care. This might avoid a future loss to follow-up. We showed that many parents prefer a clinic-based model of follow-up by paediatric oncologists or a MDT. However, parents also valued the follow-up care model according to which their child is followed up.
